Page last updated: 2024-08-26

imipenem, anhydrous and Infections, Coronavirus

imipenem, anhydrous has been researched along with Infections, Coronavirus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, DG; Kong, DP; Su, L; Tu, Y; Wang, ZB; Zhang, CX; Zhang, WN; Zhuang, CL1
Al-Tawfiq, JA; Dib, J; Memish, ZA; Momattin, H1

Other Studies

2 other study(ies) available for imipenem, anhydrous and Infections, Coronavirus

ArticleYear
Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131

    Topics: Acute Lung Injury; Animals; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Drug Repositioning; Guanine; Humans; Imipenem; Interleukin-10; Leukocytes, Mononuclear; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Pandemics; Pneumonia, Viral; Tumor Necrosis Factor-alpha

2020
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 20

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus; Coronavirus Infections; Critical Illness; Diabetes Mellitus; Female; Humans; Hypertension; Imipenem; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult

2014